← All organizations

Illinois Retina and Eye Associates

Academic/Hospital

Also known as: Kamal Kishore, MD

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

May 1, 2015

Timeline

No events for the selected filters.

Drugs by trial phase (1 distinct, 1 trials)

Phase 1 (1 own, 0 via acquisition)

aflibercept

Indications

Studied for

Recent trials (3)

NCT02403128Overall official - principal investigatorPhase 1May 1, 2015
NCT02403128Sponsor investigatorPhase 1May 1, 2015
NCT02403128Lead sponsorPhase 1May 1, 2015

Details

Last known activity: May 1, 2015